{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:22:38Z","timestamp":1781140958671,"version":"3.54.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T012978\/1"],"award-info":[{"award-number":["MR\/T012978\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cyclosporin A (CsA) induces DNA double-strand breaks in LIG4 syndrome fibroblasts, specifically upon transit through S-phase. The basis underlying this has not been described. CsA-induced genomic instability may reflect a direct role of Cyclophilin A (CYPA) in DNA repair. CYPA is a peptidyl-prolyl\n                    <jats:italic>cis-trans<\/jats:italic>\n                    isomerase (PPI). CsA inhibits the PPI activity of CYPA. Using an integrated approach involving CRISPR\/Cas9-engineering, siRNA, BioID, co-immunoprecipitation, pathway-specific DNA repair investigations as well as protein expression interaction analysis, we describe novel impacts of CYPA loss and inhibition on DNA repair. We characterise a direct CYPA interaction with the NBS1 component of the MRE11-RAD50-NBS1 complex, providing evidence that CYPA influences DNA repair at the level of DNA end resection. We define a set of genetic vulnerabilities associated with CYPA loss and inhibition, identifying DNA replication fork protection as an important determinant of viability. We explore examples of how CYPA inhibition may be exploited to selectively kill cancers sharing characteristic genomic instability profiles, including MYCN-driven Neuroblastoma, Multiple Myeloma and Chronic Myelogenous Leukaemia. These findings propose a repurposing strategy for Cyclophilin inhibitors.\n                  <\/jats:p>","DOI":"10.1038\/s44319-024-00184-9","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T16:28:31Z","timestamp":1719592111000},"page":"3432-3455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6444-5226","authenticated-orcid":false,"given":"Marisa","family":"Bedir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1311-6983","authenticated-orcid":false,"given":"Emily","family":"Outwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Colnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0353-5230","authenticated-orcid":false,"given":"Lydia","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-3597","authenticated-orcid":false,"given":"Iga","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-316X","authenticated-orcid":false,"given":"Mark","family":"O\u2019Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"184_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BJ20150396","volume":"469","author":"BM Adams","year":"2015","unstructured":"Adams BM, Coates MN, Jackson SR, Jurica MS, Davis TL (2015) Nuclear cyclophilins affect spliceosome assembly and function in vitro. Biochem J 469:223\u2013233","journal-title":"Biochem J"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pbiomolbio.2016.12.003","volume":"127","author":"AW Almawi","year":"2017","unstructured":"Almawi AW, Matthews LA, Guarn\u00e9 A (2017) FHA domains: phosphopeptide binding and beyond. Prog Biophys Mol Biol 127:105\u2013110","journal-title":"Prog Biophys Mol Biol"},{"key":"184_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2021.103181","volume":"106","author":"AM Al-Zain","year":"2021","unstructured":"Al-Zain AM, Symington LS (2021) The dark side of homology-directed repair. DNA Repair 106:103181","journal-title":"DNA Repair"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"9515","DOI":"10.1021\/bi0350710","volume":"42","author":"AH Andreotti","year":"2003","unstructured":"Andreotti AH (2003) Native state proline isomerization:\u2009 an intrinsic molecular switch. Biochemistry 42:9515\u20139524","journal-title":"Biochemistry"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.dnarep.2017.06.013","volume":"56","author":"SN Andres","year":"2017","unstructured":"Andres SN, Williams RS (2017) CtIP\/Ctp1\/Sae2, molecular form fit for function. DNA Repair 56:109\u2013117","journal-title":"DNA Repair"},{"key":"184_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23691-y","volume":"12","author":"M Babu","year":"2021","unstructured":"Babu M, Favretto F, de Opakua AI, Rankovic M, Becker S, Zweckstetter M (2021) Proline\/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis. Nat Commun 12:3396","journal-title":"Nat Commun"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"16157","DOI":"10.1021\/jacs.2c07149","volume":"144","author":"M Babu","year":"2022","unstructured":"Babu M, Favretto F, Rankovic M, Zweckstetter M (2022) Peptidyl prolyl isomerase A modulates the liquid-liquid phase separation of proline-rich IDPs. J Am Chem Soc 144:16157\u201316163","journal-title":"J Am Chem Soc"},{"key":"184_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41580-020-0257-5","volume":"21","author":"M Berti","year":"2020","unstructured":"Berti M, Cortez D, Lopes M (2020) The plasticity of DNA replication forks in response to clinically relevant genotoxic stress. Nat Rev Mol Cell Biol 21:633\u2013651","journal-title":"Nat Rev Mol Cell Biol"},{"key":"184_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17324-z","volume":"11","author":"M Berti","year":"2020","unstructured":"Berti M, Teloni F, Mijic S, Ursich S, Fuchs J, Palumbieri MD, Krietsch J, Schmid JA, Garcin EB, Gon S et al (2020) Sequential role of RAD51 paralog complexes in replication fork remodeling and restart. Nat Commun 11:3531","journal-title":"Nat Commun"},{"key":"184_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102313","volume":"67","author":"D Bhattacharya","year":"2022","unstructured":"Bhattacharya D, Sahoo S, Nagraj T, Dixit S, Dwivedi HK, Nagaraju G (2022) RAD51 paralogs: expanding roles in replication stress responses and repair. Curr Opin Pharm 67:102313","journal-title":"Curr Opin Pharm"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/leu.2010.238","volume":"25","author":"D Bixby","year":"2011","unstructured":"Bixby D, Talpaz M (2011) Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia 25:7\u201322","journal-title":"Leukemia"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3997","volume":"5","author":"N Bolli","year":"2014","unstructured":"Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, Dawson KJ, Iorio F, Nik-Zainal S, Bignell GR et al (2014) Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 5:1\u201313","journal-title":"Nat Commun"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-genet-021920-092410","volume":"54","author":"B Bonilla","year":"2020","unstructured":"Bonilla B, Hengel SR, Grundy MK, Bernstein KA (2020) RAD51 gene family structure and function. Annu Rev Genet 54:25\u201346","journal-title":"Annu Rev Genet"},{"key":"184_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nsmb.1831","volume":"17","author":"P Bouwman","year":"2010","unstructured":"Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q et al (2010) 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol 17:688\u2013695","journal-title":"Nat Struct Mol Biol"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"9710","DOI":"10.1093\/nar\/gkaa723","volume":"48","author":"S Britton","year":"2020","unstructured":"Britton S, Chanut P, Delteil C, Barboule N, Frit P, Calsou P (2020) ATM antagonizes NHEJ proteins assembly and DNA-ends synapsis at single-ended DNA double strand breaks. Nucleic Acids Res 48:9710\u20139723","journal-title":"Nucleic Acids Res"},{"key":"184_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","volume":"141","author":"SF Bunting","year":"2010","unstructured":"Bunting SF, Call\u00e9n E, Wong N, Chen H-T, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L et al (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141:243\u2013254","journal-title":"Cell"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.molcel.2009.06.037","volume":"35","author":"L Cao","year":"2009","unstructured":"Cao L, Xu X, Bunting SF, Liu J, Wang R-H, Cao LL, Wu JJ, Peng T-N, Chen J, Nussenzweig A et al (2009) A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol Cell 35:534\u2013541","journal-title":"Mol Cell"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1073\/pnas.0910684107","volume":"107","author":"H Car\u00e9n","year":"2010","unstructured":"Car\u00e9n H, Kryh H, Nethander M, Sj\u00f6berg RM, Tr\u00e4ger C, Nilsson S, Abrahamsson J, Kogner P, Martinsson T (2010) High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proc Natl Acad Sci USA 107:4323\u20134328","journal-title":"Proc Natl Acad Sci USA"},{"key":"184_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-genet-071719-020312","volume":"55","author":"P Cejka","year":"2021","unstructured":"Cejka P, Symington LS (2021) DNA end resection: mechanism and control. Annu Rev Genet 55:285\u2013307","journal-title":"Annu Rev Genet"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"21944","DOI":"10.1074\/jbc.M211689200","volume":"278","author":"KM Cerosaletti","year":"2003","unstructured":"Cerosaletti KM, Concannon P (2003) Nibrin forkhead-associated domain and breast cancer C-terminal domain are both required for nuclear focus formation and phosphorylation. J Biol Chem 278:21944\u201321951","journal-title":"J Biol Chem"},{"key":"184_CR21","first-page":"1499","volume":"2","author":"HS Chan","year":"1996","unstructured":"Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O\u2019Brien JM, Koren G, Giesbrecht E, Haddad G, Verjee Z et al (1996) Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 2:1499\u20131508","journal-title":"Clin Cancer Res"},{"key":"184_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12889","volume":"7","author":"P Chanut","year":"2016","unstructured":"Chanut P, Britton S, Coates J, Jackson SP, Calsou P (2016) Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks. Nat Commun 7:12889","journal-title":"Nat Commun"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/embor.2008.103","volume":"9","author":"JR Chapman","year":"2008","unstructured":"Chapman JR, Jackson SP (2008) Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep 9:795\u2013801","journal-title":"EMBO Rep"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41591-021-01232-w","volume":"27","author":"YC Cohen","year":"2021","unstructured":"Cohen YC, Zada M, Wang SY, Bornstein C, David E, Moshe A, Li B, Shlomi-Loubaton S, Gatt ME, Gur C et al (2021) Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nat Med 27:491\u2013503","journal-title":"Nat Med"},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1073\/pnas.1012351108","volume":"108","author":"KA Cole","year":"2011","unstructured":"Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, Diskin SJ, Attiyeh EF, Sennett R, Norris G et al (2011) RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci USA 108:3336\u20133341","journal-title":"Proc Natl Acad Sci USA"},{"key":"184_CR26","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1038\/onc.2017.40","volume":"36","author":"V Colicchia","year":"2017","unstructured":"Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sah\u00fan-Roncero M, Carbonari M, Ricci B, Heil C, Capalbo C, Belardinilli F et al (2017) PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene 36:4682\u20134691","journal-title":"Oncogene"},{"key":"184_CR27","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2014-10-567370","volume":"125","author":"J Corre","year":"2015","unstructured":"Corre J, Munshi N, Avet-Loiseau H (2015) Genetics of multiple myeloma: another heterogeneity level? Blood 125:1870\u20131876","journal-title":"Blood"},{"key":"184_CR28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-05-501072","volume":"122","author":"K Cramer-Morales","year":"2013","unstructured":"Cramer-Morales K, Nieborowska-Skorska M, Scheibner K, Padget M, Irvine DA, Sliwinski T, Haas K, Lee J, Geng H, Roy D et al (2013) Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood 122:1293\u20131304","journal-title":"Blood"},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.antiviral.2009.10.009","volume":"85","author":"D Daelemans","year":"2010","unstructured":"Daelemans D, Dumont J-M, Rosenwirth B, De Clercq E, Pannecouque C (2010) Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle. Antivir Res 85:418\u2013421","journal-title":"Antivir Res"},{"key":"184_CR30","doi-asserted-by":"publisher","first-page":"e1000439","DOI":"10.1371\/journal.pbio.1000439","volume":"8","author":"TL Davis","year":"2010","unstructured":"Davis TL, Walker JR, Campagna-Slater V, Finerty Jr. PJ, Paramanathan R, Bernstein G, MacKenzie F, Tempel W, Ouyang H, Lee WH et al (2010) Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol 8:e1000439","journal-title":"PLoS Biol"},{"key":"184_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/1541-7786.MCR-19-1144","volume":"18","author":"V Davra","year":"2020","unstructured":"Davra V, Saleh T, Geng K, Kimani S, Mehta D, Kasikara C, Smith B, Colangelo NW, Ciccarelli B, Li H et al (2020) Cyclophilin A inhibitor Debio-025 targets Crk, reduces metastasis, and induces tumor immunogenicity in breast cancer. Mol Cancer Res 18:1189\u20131201","journal-title":"Mol Cancer Res"},{"key":"184_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1363-4","volume":"571","author":"M Daza-Martin","year":"2019","unstructured":"Daza-Martin M, Starowicz K, Jamshad M, Tye S, Ronson GE, MacKay HL, Chauhan AS, Walker AK, Stone HR, Beesley JFJ et al (2019) Isomerization of BRCA1-BARD1 promotes replication fork protection. Nature 571:521\u2013527","journal-title":"Nature"},{"key":"184_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcdb.2020.10.006","volume":"112","author":"M Diaz-delCastillo","year":"2021","unstructured":"Diaz-delCastillo M, Chantry AD, Lawson MA, Heegaard AM (2021) Multiple myeloma-A painful disease of the bone marrow. Semin Cell Dev Biol 112:49\u201358","journal-title":"Semin Cell Dev Biol"},{"key":"184_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1139\/bcb-2018-0328","volume":"98","author":"D Dilworth","year":"2020","unstructured":"Dilworth D, Gong F, Miller K, Nelson CJ (2020) FKBP25 participates in DNA double-strand break repair. Biochem Cell Biol 98:42\u201349","journal-title":"Biochem Cell Biol"},{"key":"184_CR35","doi-asserted-by":"publisher","first-page":"e0145744","DOI":"10.1371\/journal.pone.0145744","volume":"10","author":"ME Dolman","year":"2015","unstructured":"Dolman ME, van der Ploeg I, Koster J, Bate-Eya LT, Versteeg R, Caron HN, Molenaar JJ (2015) DNA-dependent protein kinase as molecular target for radiosensitization of neuroblastoma cells. PLoS One 10:e0145744","journal-title":"PLoS One"},{"key":"184_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1167\/iovs.04-1022","volume":"46","author":"LA Eckstein","year":"2005","unstructured":"Eckstein LA, Van Quill KR, Bui SK, Uusitalo MS, O\u2019Brien JM (2005) Cyclosporin A inhibits calcineurin\/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells. Investig Ophthalmol Vis Sci 46:782\u2013790","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"184_CR37","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1002\/anie.201914878","volume":"59","author":"F Favretto","year":"2020","unstructured":"Favretto F, Baker JD, Stroh\u00e4ker T, Andreas LB, Blair LJ, Becker S, Zweckstetter M (2020a) The molecular basis of the interaction of cyclophilin A with \u03b1-Synuclein. Angew Chem Int 59:5643\u20135646","journal-title":"Angew Chem Int"},{"key":"184_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19844-0","volume":"11","author":"F Favretto","year":"2020","unstructured":"Favretto F, Flores D, Baker JD, Stroh\u00e4ker T, Andreas LB, Blair LJ, Becker S, Zweckstetter M (2020b) Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war. Nat Commun 11:6046","journal-title":"Nat Commun"},{"key":"184_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1101\/sqb.2017.82.035006","volume":"82","author":"W Feng","year":"2017","unstructured":"Feng W, Jasin M (2017) Homologous recombination and replication fork protection: BRCA2 and more! Cold Spring Harb Symp Quant Biol 82:329\u2013338","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"184_CR40","doi-asserted-by":"publisher","unstructured":"Fischer G, Malesevic M (2013) Cyclosporin. eLS https:\/\/doi.org\/10.1002\/9780470015902.a0024215","DOI":"10.1002\/9780470015902.a0024215"},{"key":"184_CR41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/337476a0","volume":"337","author":"G Fischer","year":"1989","unstructured":"Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX (1989) Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476\u2013478","journal-title":"Nature"},{"key":"184_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11901-012-0136-4","volume":"11","author":"R Flisiak","year":"2012","unstructured":"Flisiak R, Parfienniuk-Kowerda A (2012) Cyclophilin Inhibitors. Curr Hepatol Rep 11:153\u2013159","journal-title":"Curr Hepatol Rep"},{"key":"184_CR43","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.tiv.2009.09.001","volume":"23","author":"I Frydrych","year":"2009","unstructured":"Frydrych I, Mlejnek P, Dolezel P (2009) Cyclosporin A sensitises Bcr-Abl positive cells to imatinib mesylate independently of P-glycoprotein expression. Toxicol Vitr 23:1482\u20131490","journal-title":"Toxicol Vitr"},{"key":"184_CR44","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.1021\/jm500862r","volume":"57","author":"J Fu","year":"2014","unstructured":"Fu J, Tjandra M, Becker C, Bednarczyk D, Capparelli M, Elling R, Hanna I, Fujimoto R, Furegati M, Karur S et al (2014) Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition. J Med Chem 57:8503\u20138516","journal-title":"J Med Chem"},{"key":"184_CR45","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1038\/s41388-022-02299-6","volume":"41","author":"H Fujita","year":"2022","unstructured":"Fujita H, Ikeda M, Ui A, Ouchi Y, Mikami Y, Kanno SI, Yasui A, Tanaka K (2022) CHAMP1-POGZ counteracts the inhibitory effect of 53BP1 on homologous recombination and affects PARP inhibitor resistance. Oncogene 41:2706\u20132718","journal-title":"Oncogene"},{"key":"184_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard H, Garcia-Muse T, Aguilera A (2015) Replication stress and cancer. Nat Rev Cancer 15:276\u2013289","journal-title":"Nat Rev Cancer"},{"key":"184_CR47","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.cell.2018.03.050","volume":"173","author":"R Gupta","year":"2018","unstructured":"Gupta R, Somyajit K, Narita T, Maskey E, Stanlie A, Kremer M, Typas D, Lammers M, Mailand N, Nussenzweig A et al (2018) DNA repair network analysis reveals shieldin as a key regulator of NHEJ and PARP inhibitor sensitivity. Cell 173:972\u2013988.e923","journal-title":"Cell"},{"key":"184_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101581","volume":"23","author":"S Hakim","year":"2020","unstructured":"Hakim S, Craig JM, Koblinski JE, Clevenger CV (2020) Inhibition of the activity of cyclophilin A impedes prolactin receptor-mediated signaling, mammary tumorigenesis, and metastases. iScience 23:101581","journal-title":"iScience"},{"key":"184_CR49","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.molonc.2016.07.012","volume":"10","author":"RM Hallett","year":"2016","unstructured":"Hallett RM, Seong ABK, Kaplan DR, Irwin MS (2016) Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma. Mol Oncol 10:1461\u20131472","journal-title":"Mol Oncol"},{"key":"184_CR50","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.drudis.2022.05.016","volume":"27","author":"J Han","year":"2022","unstructured":"Han J, Lee MK, Jang Y, Cho WJ, Kim M (2022) Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents. Drug Discov Today 27:1895\u20131912","journal-title":"Drug Discov Today"},{"key":"184_CR51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1126\/science.6238408","volume":"226","author":"RE Handschumacher","year":"1984","unstructured":"Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544\u2013547","journal-title":"Science"},{"key":"184_CR52","doi-asserted-by":"publisher","first-page":"29s","DOI":"10.1097\/00007890-198808001-00006","volume":"46","author":"MW Harding","year":"1988","unstructured":"Harding MW, Handschumacher RE (1988) Cyclophilin, a primary molecular target for cyclosporine. Structural and functional implications. Transplantation 46:29s\u201335s","journal-title":"Transplantation"},{"key":"184_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4448","volume":"31","author":"SE Hill","year":"2022","unstructured":"Hill SE, Esquivel AR, Ospina SR, Rahal LM, Dickey CA, Blair LJ (2022) Chaperoning activity of the cyclophilin family prevents tau aggregation. Protein Sci 31:e4448","journal-title":"Protein Sci"},{"key":"184_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molcel.2015.08.008","volume":"60","author":"BA Hilton","year":"2015","unstructured":"Hilton BA, Li Z, Musich PR, Wang H, Cartwright BM, Serrano M, Zhou XZ, Lu KP, Zou Y (2015) ATR plays a direct antiapoptotic role at mitochondria, which is regulated by prolyl isomerase Pin1. Mol Cell 60:35\u201346","journal-title":"Mol Cell"},{"key":"184_CR55","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1093\/bioinformatics\/btu581","volume":"30","author":"G Hu","year":"2014","unstructured":"Hu G, Wang K, Groenendyk J, Barakat K, Mizianty MJ, Ruan J, Michalak M, Kurgan L (2014) Human structural proteome-wide characterization of Cyclosporine A targets. Bioinformatics 30:3561\u20133566","journal-title":"Bioinformatics"},{"key":"184_CR56","first-page":"77","volume":"50","author":"IARC","year":"1990","unstructured":"IARC (1990) Ciclosporin. IARC Monogr Eval Carcinog Risks Hum 50:77\u2013114","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"184_CR157","doi-asserted-by":"crossref","unstructured":"Jumper J et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589","DOI":"10.1038\/s41586-021-03819-2"},{"key":"184_CR57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1006\/jmbi.1998.2108","volume":"283","author":"J Kallen","year":"1998","unstructured":"Kallen J, Mikol V, Taylor P, D.Walkinshaw M (1998) X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A. J Mol Biol 283:435\u2013449","journal-title":"J Mol Biol"},{"key":"184_CR58","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1038\/emboj.2010.204","volume":"29","author":"S Karmakar","year":"2010","unstructured":"Karmakar S, Mahajan MC, Schulz V, Boyapaty G, Weissman SM (2010) A multiprotein complex necessary for both transcription and DNA replication at the \u03b2-globin locus. EMBO J 29:3260\u20133271","journal-title":"EMBO J"},{"key":"184_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88400-7","volume":"11","author":"K Kim","year":"2021","unstructured":"Kim K, Kirby TW, Perera L, London RE (2021) Phosphopeptide interactions of the Nbs1 N-terminal FHA-BRCT1\/2 domains. Sci Rep 11:9046","journal-title":"Sci Rep"},{"key":"184_CR60","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.18632\/oncotarget.27329","volume":"11","author":"D King","year":"2020","unstructured":"King D, Li XD, Almeida GS, Kwok C, Gravells P, Harrison D, Burke S, Hallsworth A, Jamin Y, George S et al (2020) MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget 11:2141\u20132159","journal-title":"Oncotarget"},{"key":"184_CR61","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.3390\/cancers13246215","volume":"13","author":"D King","year":"2021","unstructured":"King D, Southgate HED, Roetschke S, Gravells P, Fields L, Watson JB, Chen L, Chapman D, Harrison D, Yeomanson D et al (2021) Increased replication stress determines ATR inhibitor sensitivity in neuroblastoma cells. Cancers 13:6215","journal-title":"Cancers"},{"key":"184_CR62","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/1873-3468.12556","volume":"591","author":"AM Kolinjivadi","year":"2017","unstructured":"Kolinjivadi AM, Sannino V, de Antoni A, T\u00e9cher H, Baldi G, Costanzo V (2017) Moonlighting at replication forks\u2014a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51. FEBS Lett 591:1083\u20131100","journal-title":"FEBS Lett"},{"key":"184_CR63","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tig.2018.04.002","volume":"34","author":"J Kramara","year":"2018","unstructured":"Kramara J, Osia B, Malkova A (2018) Break-induced replication: the where, the why, and the how. Trends Genet 34:518\u2013531","journal-title":"Trends Genet"},{"key":"184_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC (2017) Multiple myeloma. Nat Rev Dis Prim 3:17046","journal-title":"Nat Rev Dis Prim"},{"key":"184_CR65","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1124\/jpet.119.261099","volume":"371","author":"J Kuo","year":"2019","unstructured":"Kuo J, Bobardt M, Chatterji U, Mayo PR, Trepanier DJ, Foster RT, Gallay P, Ure DR (2019) A pan-cyclophilin inhibitor, CRV431, decreases fibrosis and tumor development in chronic liver disease models. J Pharm Exp Ther 371:231\u2013241","journal-title":"J Pharm Exp Ther"},{"key":"184_CR66","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.bbagen.2014.12.023","volume":"1850","author":"ST Ladani","year":"2015","unstructured":"Ladani ST, Souffrant MG, Barman A, Hamelberg D (2015) Computational perspective and evaluation of plausible catalytic mechanisms of peptidyl-prolyl cis-trans isomerases. Biochim Biophys Acta 1850:1994\u20132004","journal-title":"Biochim Biophys Acta"},{"key":"184_CR67","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/brain\/awv005","volume":"138","author":"E Lauranzano","year":"2015","unstructured":"Lauranzano E, Pozzi S, Pasetto L, Stucchi R, Massignan T, Paolella K, Mombrini M, Nardo G, Lunetta C, Corbo M et al (2015) Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes. Brain 138:974\u2013991","journal-title":"Brain"},{"issue":"Pt 2","key":"184_CR68","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/bj3000395","volume":"300","author":"A Lawen","year":"1994","unstructured":"Lawen A, Traber R, Reuille R, Ponelle M (1994) In vitro biosynthesis of ring-extended cyclosporins. Biochem J 300(Pt 2):395\u2013399","journal-title":"Biochem J"},{"key":"184_CR69","doi-asserted-by":"publisher","first-page":"e202008030","DOI":"10.1083\/jcb.202008030","volume":"220","author":"BR Levone","year":"2021","unstructured":"Levone BR, Lenzken SC, Antonaci M, Maiser A, Rapp A, Conte F, Reber S, Mechtersheimer J, Ronchi AE, M\u00fchlemann O et al (2021) FUS-dependent liquid-liquid phase separation is important for DNA repair initiation. J Cell Biol 220:e202008030","journal-title":"J Cell Biol"},{"key":"184_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111297","volume":"40","author":"F Li","year":"2022","unstructured":"Li F, Sarangi P, Iyer DR, Feng H, Moreau L, Nguyen H, Clairmont C, D\u2019Andrea AD (2022) CHAMP1 binds to REV7\/FANCV and promotes homologous recombination repair. Cell Rep 40:111297","journal-title":"Cell Rep"},{"key":"184_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cell.2009.07.043","volume":"139","author":"J Lloyd","year":"2009","unstructured":"Lloyd J, Chapman JR, Clapperton JA, Haire LF, Hartsuiker E, Li J, Carr AM, Jackson SP, Smerdon SJ (2009) A supramodular FHA\/BRCT-repeat architecture mediates Nbs1 adaptor function in response to DNA damage. Cell 139:100\u2013111","journal-title":"Cell"},{"key":"184_CR72","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nchembio.2007.35","volume":"3","author":"KP Lu","year":"2007","unstructured":"Lu KP, Finn G, Lee TH, Nicholson LK (2007) Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol 3:619\u2013629","journal-title":"Nat Chem Biol"},{"key":"184_CR73","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1038\/onc.2017.41","volume":"36","author":"W Lu","year":"2017","unstructured":"Lu W, Cheng F, Yan W, Li X, Yao X, Song W, Liu M, Shen X, Jiang H, Chen J et al (2017) Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. Oncogene 36:4719\u20134731","journal-title":"Oncogene"},{"key":"184_CR74","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1158\/0008-5472.CAN-19-2739","volume":"80","author":"ML Luo","year":"2020","unstructured":"Luo ML, Zheng F, Chen W, Liang ZM, Chandramouly G, Tan J, Willis NA, Chen CH, Taveira MO, Zhou XZ et al (2020) Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition. Cancer Res 80:3033\u20133045","journal-title":"Cancer Res"},{"key":"184_CR75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.dnarep.2015.04.016","volume":"32","author":"N Makharashvili","year":"2015","unstructured":"Makharashvili N, Paull TT (2015) CtIP: A DNA damage response protein at the intersection of DNA metabolism. DNA Repair 32:75\u201381","journal-title":"DNA Repair"},{"key":"184_CR76","doi-asserted-by":"crossref","unstructured":"Maneix L, Iakova P, Lee CG, Moree SE, Lu X, Datar GK, Hill CT, Spooner E, King JCK, Sykes DB et al (2024) Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageing. Nat Cell Biol 26(4):593\u2013603","DOI":"10.1038\/s41556-024-01387-x"},{"key":"184_CR77","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1242\/jcs.004580","volume":"120","author":"KC Manthey","year":"2007","unstructured":"Manthey KC, Opiyo S, Glanzer JG, Dimitrova D, Elliott J, Oakley GG (2007) NBS1 mediates ATR-dependent RPA hyperphosphorylation following replication-fork stall and collapse. J Cell Sci 120:4221\u20134229","journal-title":"J Cell Sci"},{"key":"184_CR78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ccell.2017.05.011","volume":"32","author":"M Marchesini","year":"2017","unstructured":"Marchesini M, Ogoti Y, Fiorini E, Aktas Samur A, Nezi L, D\u2019Anca M, Storti P, Samur MK, Ganan-Gomez I, Fulciniti MT et al (2017) ILF2 is a regulator of RNA splicing and DNA damage response in 1q21-amplified multiple myeloma. Cancer Cell 32:88\u2013100.e106","journal-title":"Cancer Cell"},{"key":"184_CR79","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM (2010) Recent advances in neuroblastoma. New Engl J Med 362:2202\u20132211","journal-title":"New Engl J Med"},{"key":"184_CR80","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0192-0561(90)90109-Z","volume":"12","author":"G McLachlan","year":"1990","unstructured":"McLachlan G, Smart LM, Wallace HM, Thomson AW (1990) The potential of cyclosporin A as an anti-tumour agent. Int J Immunopharmacol 12:469\u2013479","journal-title":"Int J Immunopharmacol"},{"key":"184_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1083\/jcb.200708210","volume":"181","author":"F Melander","year":"2008","unstructured":"Melander F, Bekker-Jensen S, Falck J, Bartek J, Mailand N, Lukas J (2008) Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J Cell Biol 181:213\u2013226","journal-title":"J Cell Biol"},{"key":"184_CR159","doi-asserted-by":"crossref","unstructured":"Mirdita M, Sch\u00fctze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M (2022) ColabFold: making protein folding accessible to all. Nat Methods 19:679\u2013682","DOI":"10.1038\/s41592-022-01488-1"},{"key":"184_CR82","doi-asserted-by":"publisher","first-page":"12968","DOI":"10.1073\/pnas.0901418106","volume":"106","author":"JJ Molenaar","year":"2009","unstructured":"Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN (2009) Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci USA 106:12968\u201312973","journal-title":"Proc Natl Acad Sci USA"},{"key":"184_CR83","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S1470-2045(20)30756-7","volume":"22","author":"P Moreau","year":"2021","unstructured":"Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, Mikhael J, Terpos E, Schjesvold F et al (2021) Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Lancet Oncol 22:e105\u2013e118","journal-title":"Lancet Oncol"},{"key":"184_CR84","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1525-1438.2007.00787.x","volume":"17","author":"RJJ Morgan","year":"2007","unstructured":"Morgan RJJ, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S et al (2007) Phase II trial of carboplatin and infusional cyclosporine with alpha\u2010interferon in recurrent ovarian cancer: a California Cancer Consortium Trial. Int J Gynecol Cancer 17:373\u2013378","journal-title":"Int J Gynecol Cancer"},{"key":"184_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semcdb.2020.09.001","volume":"113","author":"NL Mozaffari","year":"2021","unstructured":"Mozaffari NL, Pagliarulo F, Sartori AA (2021) Human CtIP: a \u2018double agent\u2019 in DNA repair and tumorigenesis. Semin Cell Dev Biol 113:47\u201356","journal-title":"Semin Cell Dev Biol"},{"key":"184_CR86","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1016\/j.febslet.2010.09.021","volume":"584","author":"SN Naryzhny","year":"2010","unstructured":"Naryzhny SN, Lee H (2010) Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer. FEBS Lett 584:4292\u20134298","journal-title":"FEBS Lett"},{"key":"184_CR87","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1182\/blood-2011-06-363911","volume":"118","author":"P Neri","year":"2011","unstructured":"Neri P, Ren L, Gratton K, Stebner E, Johnson J, Klimowicz A, Duggan P, Tassone P, Mansoor A, Stewart DA et al (2011) Bortezomib-induced \u201cBRCAness\u201d sensitizes multiple myeloma cells to PARP inhibitors. Blood 118:6368\u20136379","journal-title":"Blood"},{"key":"184_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107660","volume":"31","author":"S Nourreddine","year":"2020","unstructured":"Nourreddine S, Lavoie G, Paradis J, Ben El Kadhi K, M\u00e9ant A, Aubert L, Grondin B, Gendron P, Chabot B, Bouvier M et al (2020) NF45 and NF90 regulate mitotic gene expression by competing with staufen-mediated mRNA decay. Cell Rep 31:107660","journal-title":"Cell Rep"},{"key":"184_CR89","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/bmt.2008.18","volume":"41","author":"M O\u2019Driscoll","year":"2008","unstructured":"O\u2019Driscoll M, Jeggo PA (2008) CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair. Bone Marrow Transpl 41:983\u2013989","journal-title":"Bone Marrow Transpl"},{"key":"184_CR90","first-page":"273","volume":"2","author":"VD Oliveira","year":"2004","unstructured":"Oliveira VD, Zankl H, Rath T (2004) Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Exp Clin Transpl 2:273\u2013279","journal-title":"Exp Clin Transpl"},{"key":"184_CR91","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/gte.2008.0006","volume":"12","author":"S Ozt\u00fcrk","year":"2008","unstructured":"Ozt\u00fcrk S, Ayna TK, Cefle K, Palanduz S, Cift\u00e7i HS, Kaya SA, Diler AS, T\u00fcrkmen A, G\u00fcrtekin M, Sever MS, Carin M (2008) Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients. Genet Test 12:427\u2013430","journal-title":"Genet Test"},{"key":"184_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1007594421458","volume":"15","author":"\u015e Palanduz","year":"1999","unstructured":"Palanduz \u015e, Sever M\u015e, \u00f6zt\u00fcrk \u015e, Ta\u015f\u00e7io\u011flu C, Karan MA, S\u00f6nmez G, \u00c7efle K, G\u00fcler K (1999) Genotoxic potential of cyclosporin A in patients with renal transplantation. Cell Biol Toxicol 15:13\u201317","journal-title":"Cell Biol Toxicol"},{"key":"184_CR93","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K (2011) Multiple myeloma. New Engl J Med 364:1046\u20131060","journal-title":"New Engl J Med"},{"key":"184_CR94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-genet-120116-024745","volume":"51","author":"P Pasero","year":"2017","unstructured":"Pasero P, Vindigni A (2017) Nucleases acting at stalled forks: how to reboot the replication program with a few shortcuts. Annu Rev Genet 51:477\u2013499","journal-title":"Annu Rev Genet"},{"key":"184_CR95","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1093\/brain\/awab333","volume":"144","author":"L Pasetto","year":"2021","unstructured":"Pasetto L, Grassano M, Pozzi S, Luotti S, Sammali E, Migazzi A, Basso M, Spagnolli G, Biasini E, Micotti E et al (2021) Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia. Brain 144:3710\u20133726","journal-title":"Brain"},{"key":"184_CR96","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1523\/JNEUROSCI.2462-16.2016","volume":"37","author":"L Pasetto","year":"2017","unstructured":"Pasetto L, Pozzi S, Castelnovo M, Basso M, Estevez AG, Fumagalli S, De Simoni MG, Castellaneta V, Bigini P, Restelli E et al (2017) Targeting extracellular cyclophilin A reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis. J Neurosci 37:1413\u20131427","journal-title":"J Neurosci"},{"key":"184_CR97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.molcel.2018.06.033","volume":"71","author":"TT Paull","year":"2018","unstructured":"Paull TT (2018) 20 Years of Mre11 biology: no end in sight. Mol Cell 71:419\u2013427","journal-title":"Mol Cell"},{"key":"184_CR98","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.bbagen.2015.02.008","volume":"1850","author":"M Peel","year":"2015","unstructured":"Peel M, Scribner A (2015) Semi-synthesis of cyclosporins. Biochim Biophys Acta 1850:2121\u20132144","journal-title":"Biochim Biophys Acta"},{"key":"184_CR99","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.str.2010.09.014","volume":"18","author":"S Pennell","year":"2010","unstructured":"Pennell S, Westcott S, Ortiz-Lombard\u00eda M, Patel D, Li J, Nott TJ, Mohammed D, Buxton RS, Yaffe MB, Verma C, Smerdon SJ (2010) Structural and functional analysis of phosphothreonine-dependent FHA domain interactions. Structure 18:1587\u20131595","journal-title":"Structure"},{"key":"184_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0924-z","volume":"9","author":"M Petroni","year":"2018","unstructured":"Petroni M, Sardina F, Infante P, Bartolazzi A, Locatelli E, Fabretti F, Di Giulio S, Capalbo C, Cardinali B, Coppa A et al (2018) MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors. Cell Death Dis 9:895","journal-title":"Cell Death Dis"},{"key":"184_CR101","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.leu.2400984","volume":"12","author":"LM Pilarski","year":"1998","unstructured":"Pilarski LM, Yatscoff RW, Murphy GF, Belch AR (1998) Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers. Leukemia 12:505\u2013509","journal-title":"Leukemia"},{"key":"184_CR102","doi-asserted-by":"publisher","first-page":"a016600","DOI":"10.1101\/cshperspect.a016600","volume":"7","author":"R Prakash","year":"2015","unstructured":"Prakash R, Zhang Y, Feng W, Jasin M (2015) Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol 7:a016600","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"184_CR103","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2529","volume":"45","author":"TJ Pugh","year":"2013","unstructured":"Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A et al (2013) The genetic landscape of high-risk neuroblastoma. Nat Genet 45:279\u2013284","journal-title":"Nat Genet"},{"key":"184_CR104","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/biom8040161","volume":"8","author":"C Rajiv","year":"2018","unstructured":"Rajiv C, Davis TL (2018) Structural and functional insights into human nuclear cyclophilins. Biomolecules 8:161","journal-title":"Biomolecules"},{"key":"184_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2020.102869","volume":"91-92","author":"G Reginato","year":"2020","unstructured":"Reginato G, Cejka P (2020) The MRE11 complex: a versatile toolkit for the repair of broken DNA. DNA Repair 91-92:102869","journal-title":"DNA Repair"},{"key":"184_CR106","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","volume":"8","author":"DS Rickman","year":"2018","unstructured":"Rickman DS, Schulte JH, Eilers M (2018) The expanding world of N-MYC-driven tumors. Cancer Discov 8:150\u2013163","journal-title":"Cancer Discov"},{"key":"184_CR107","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molcel.2022.12.003","volume":"83","author":"M Rotheneder","year":"2023","unstructured":"Rotheneder M, Stakyte K, van de Logt E, Bartho JD, Lammens K, Fan Y, Alt A, Kessler B, Jung C, Roos WP et al (2023) Cryo-EM structure of the Mre11-Rad50-Nbs1 complex reveals the molecular mechanism of scaffolding functions. Mol Cell 83:167\u2013185.e169","journal-title":"Mol Cell"},{"key":"184_CR108","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.201112098","volume":"196","author":"KJ Roux","year":"2012","unstructured":"Roux KJ, Kim DI, Raida M, Burke B (2012) A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol 196:801\u2013810","journal-title":"J Cell Biol"},{"key":"184_CR109","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/hlca.19760590412","volume":"59","author":"A R\u00fcegger","year":"1976","unstructured":"R\u00fcegger A, Kuhn M, Lichti H, Loosli HR, Huguenin R, Quiquerez C, von Wartburg A (1976) [Cyclosporin A, a peptide metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Helv Chim Acta 59:1075\u20131092","journal-title":"Helv Chim Acta"},{"key":"184_CR110","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1038\/sj.onc.1210428","volume":"26","author":"S Sakamoto","year":"2007","unstructured":"Sakamoto S, Iijima K, Mochizuki D, Nakamura K, Teshigawara K, Kobayashi J, Matsuura S, Tauchi H, Komatsu K (2007) Homologous recombination repair is regulated by domains at the N- and C-terminus of NBS1 and is dissociated with ATM functions. Oncogene 26:6002\u20136009","journal-title":"Oncogene"},{"key":"184_CR111","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.15252\/embj.201591697","volume":"34","author":"JE Sale","year":"2015","unstructured":"Sale JE (2015) REV7\/MAD2L2: the multitasking maestro emerges as a barrier to recombination. EMBO J 34:1609\u20131611","journal-title":"EMBO J"},{"key":"184_CR112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgq216","volume":"32","author":"D Salles","year":"2011","unstructured":"Salles D, Mencalha AL, Ireno IC, Wiesm\u00fcller L, Abdelhay E (2011) BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP. Carcinogenesis 32:27\u201334","journal-title":"Carcinogenesis"},{"key":"184_CR113","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/med.21627","volume":"40","author":"CH Schein","year":"2020","unstructured":"Schein CH (2020) Repurposing approved drugs on the pathway to novel therapies. Med Res Rev 40:586\u2013605","journal-title":"Med Res Rev"},{"key":"184_CR114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/bmb\/ldaa045","volume":"137","author":"CH Schein","year":"2021","unstructured":"Schein CH (2021) Repurposing approved drugs for cancer therapy. Br Med Bull 137:13\u201327","journal-title":"Br Med Bull"},{"key":"184_CR115","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jmb.2015.01.023","volume":"427","author":"PA Schmidpeter","year":"2015","unstructured":"Schmidpeter PA, Schmid FX (2015) Prolyl isomerization and its catalysis in protein folding and protein function. J Mol Biol 427:1609\u20131631","journal-title":"J Mol Biol"},{"key":"184_CR116","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1128\/MCB.05849-11","volume":"31","author":"RA Shamanna","year":"2011","unstructured":"Shamanna RA, Hoque M, Lewis-Antes A, Azzam EI, Lagunoff D, Pe\u2019ery T, Mathews MB (2011) The NF90\/NF45 complex participates in DNA break repair via nonhomologous end joining. Mol Cell Biol 31:4832\u20134843","journal-title":"Mol Cell Biol"},{"key":"184_CR117","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1182\/blood-2007-05-089193","volume":"113","author":"MA Shammas","year":"2009","unstructured":"Shammas MA, Shmookler Reis RJ, Koley H, Batchu RB, Li C, Munshi NC (2009) Dysfunctional homologous recombination mediates genomic instability and progression in myeloma. Blood 113:2290\u20132297","journal-title":"Blood"},{"key":"184_CR118","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.dnarep.2018.08.020","volume":"71","author":"A Shibata","year":"2018","unstructured":"Shibata A, Jeggo P, L\u00f6brich M (2018) The pendulum of the Ku-Ku clock. DNA Repair 71:164\u2013171","journal-title":"DNA Repair"},{"key":"184_CR119","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drudis.2017.08.008","volume":"23","author":"M Simsek","year":"2018","unstructured":"Simsek M, Meijer B, van Bodegraven AA, de Boer NKH, Mulder CJJ (2018) Finding hidden treasures in old drugs: the challenges and importance of licensing generics. Drug Discov Today 23:17\u201321","journal-title":"Drug Discov Today"},{"key":"184_CR120","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1038\/sj.onc.1208545","volume":"24","author":"A Slupianek","year":"2005","unstructured":"Slupianek A, Gurdek E, Koptyra M, Nowicki MO, Siddiqui KM, Groden J, Skorski T (2005) BLM helicase is activated in BCR\/\/ABL leukemia cells to modulate responses to cisplatin. Oncogene 24:3914\u20133922","journal-title":"Oncogene"},{"key":"184_CR121","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","volume":"22","author":"A Slupianek","year":"2002","unstructured":"Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, Fishel R, Skorski T (2002) Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)\/M phase, and protection from apoptosis. Mol Cell Biol 22:4189\u20134201","journal-title":"Mol Cell Biol"},{"key":"184_CR122","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.dnarep.2005.10.005","volume":"5","author":"A Slupianek","year":"2006","unstructured":"Slupianek A, Nowicki MO, Koptyra M, Skorski T (2006) BCR\/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair 5:243\u2013250","journal-title":"DNA Repair"},{"key":"184_CR123","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1097-2765(01)00357-4","volume":"8","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R, Skorski T (2001) BCR\/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 8:795\u2013806","journal-title":"Mol Cell"},{"key":"184_CR124","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0140-6736(92)92353-H","volume":"340","author":"P Sonneveld","year":"1992","unstructured":"Sonneveld P, Lowenberg B, Durie BGM, Lokhorst HM, Marie JP, Zittoun R, Solbu G, Suciu S, Nooter K (1992) Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet 340:255\u2013259","journal-title":"Lancet"},{"key":"184_CR125","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.neo.7900019","volume":"1","author":"AK Sood","year":"1999","unstructured":"Sood AK, Sorosky JI, Squatrito RC, Skilling JS, Anderson B, Buller RE (1999) Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies. Neoplasia 1:118\u2013122","journal-title":"Neoplasia"},{"key":"184_CR126","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1083\/jcb.200709008","volume":"181","author":"C Spycher","year":"2008","unstructured":"Spycher C, Miller ES, Townsend K, Pavic L, Morrice NA, Janscak P, Stewart GS, Stucki M (2008) Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J Cell Biol 181:227\u2013240","journal-title":"J Cell Biol"},{"key":"184_CR127","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/acs.jmedchem.6b01329","volume":"60","author":"VA Steadman","year":"2017","unstructured":"Steadman VA, Pettit SB, Poullennec KG, Lazarides L, Keats AJ, Dean DK, Stanway SJ, Austin CA, Sanvoisin JA, Watt GM et al (2017) Discovery of potent cyclophilin inhibitors based on the structural simplification of sanglifehrin A. J Medicinal Chem 60:1000\u20131017","journal-title":"J Medicinal Chem"},{"key":"184_CR128","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molcel.2013.03.023","volume":"50","author":"M Steger","year":"2013","unstructured":"Steger M, Murina O, H\u00fchn D, Ferretti LP, Walser R, H\u00e4nggi K, Lafranchi L, Neugebauer C, Paliwal S, Janscak P et al (2013) Prolyl isomerase PIN1 regulates DNA Double-strand break repair by counteracting DNA end resection. Mol Cell 50:333\u2013343","journal-title":"Mol Cell"},{"key":"184_CR129","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter SM (2014) Overcoming drug development bottlenecks with repurposing: old drugs learn new tricks. Nat Med 20:590\u2013591","journal-title":"Nat Med"},{"key":"184_CR130","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-biochem-062917-012415","volume":"87","author":"A Syed","year":"2018","unstructured":"Syed A, Tainer JA (2018) The MRE11-RAD50-NBS1 complex conducts the orchestration of damage signaling and outcomes to stress in DNA replication and repair. Annu Rev Biochem 87:263\u2013294","journal-title":"Annu Rev Biochem"},{"key":"184_CR131","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/337473a0","volume":"337","author":"N Takahashi","year":"1989","unstructured":"Takahashi N, Hayano T, Suzuki M (1989) Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337:473\u2013475","journal-title":"Nature"},{"key":"184_CR132","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1074\/jbc.C000578200","volume":"276","author":"H Tauchi","year":"2001","unstructured":"Tauchi H, Kobayashi J, Morishima K, Matsuura S, Nakamura A, Shiraishi T, Ito E, Masnada D, Delia D, Komatsu K (2001) The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50[middle dot]hMRE11[middle dot]NBS1 complex DNA repair activity. J Biol Chem 276:12\u201315","journal-title":"J Biol Chem"},{"key":"184_CR133","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1074\/jbc.273.4.2136","volume":"273","author":"NS Ting","year":"1998","unstructured":"Ting NS, Kao PN, Chan DW, Lintott LG, Lees-Miller SP (1998) DNA-dependent protein kinase interacts with antigen receptor response element binding proteins NF90 and NF45. J Biol Chem 273:2136\u20132145","journal-title":"J Biol Chem"},{"key":"184_CR134","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/pharmaceutics9040051","volume":"9","author":"DJ Trepanier","year":"2017","unstructured":"Trepanier DJ, Ure DR, Foster RT (2017) In vitro phase I metabolism of CRV431, a novel oral drug candidate for chronic hepatitis B. Pharmaceutics 9:51","journal-title":"Pharmaceutics"},{"key":"184_CR135","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/13543784.2020.1703948","volume":"29","author":"DR Ure","year":"2020","unstructured":"Ure DR, Trepanier DJ, Mayo PR, Foster RT (2020) Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). Expert Opin Investig Drugs 29:163\u2013178","journal-title":"Expert Opin Investig Drugs"},{"key":"184_CR158","doi-asserted-by":"crossref","unstructured":"Varadi M et al (2022) AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic acids Res 50:D439\u2013D444","DOI":"10.1093\/nar\/gkab1061"},{"key":"184_CR136","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bmb\/ldu016","volume":"111","author":"RE Walker","year":"2014","unstructured":"Walker RE, Lawson MA, Buckle CH, Snowden JA, Chantry AD (2014) Myeloma bone disease: pathogenesis, current treatments and future targets. Br Med Bull 111:117\u2013138","journal-title":"Br Med Bull"},{"key":"184_CR137","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1128\/MCB.00306-15","volume":"35","author":"F Wandrey","year":"2015","unstructured":"Wandrey F, Montellese C, Koos K, Badertscher L, Bammert L, Cook AG, Zemp I, Horvath P, Kutay U (2015) The NF45\/NF90 heterodimer contributes to the biogenesis of 60S ribosomal subunits and influences nucleolar morphology. Mol Cell Biol 35:3491\u20133503","journal-title":"Mol Cell Biol"},{"key":"184_CR138","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1158\/1078-0432.CCR-17-0774","volume":"23","author":"G Wang","year":"2017","unstructured":"Wang G, Shen J, Sun J, Jiang Z, Fan J, Wang H, Yu S, Long Y, Liu Y, Bao H et al (2017) Cyclophilin A maintains glioma-initiating cell stemness by regulating Wnt\/\u03b2-catenin signaling. Clin Cancer Res 23:6640\u20136649","journal-title":"Clin Cancer Res"},{"key":"184_CR139","doi-asserted-by":"publisher","first-page":"e1007983","DOI":"10.1371\/journal.pgen.1007983","volume":"15","author":"J Wang","year":"2019","unstructured":"Wang J, Chan B, Tong M, Paung Y, Jo U, Martin D, Seeliger M, Haley J, Kim H (2019) Prolyl isomerization of FAAP20 catalyzed by PIN1 regulates the Fanconi anemia pathway. PLoS Genet 15:e1007983","journal-title":"PLoS Genet"},{"key":"184_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2005-6-7-226","volume":"6","author":"P Wang","year":"2005","unstructured":"Wang P, Heitman J (2005) The cyclophilins. Genome Biol 6:226","journal-title":"Genome Biol"},{"key":"184_CR141","first-page":"213","volume":"11","author":"K Watashi","year":"2010","unstructured":"Watashi K (2010) Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection. Curr Opin Investig Drugs 11:213\u2013224","journal-title":"Curr Opin Investig Drugs"},{"key":"184_CR142","doi-asserted-by":"publisher","first-page":"14637","DOI":"10.1021\/bi020574b","volume":"41","author":"WJ Wedemeyer","year":"2002","unstructured":"Wedemeyer WJ, Welker E, Scheraga HA (2002a) Proline cis-trans isomerization and protein folding. Biochemistry 41:14637\u201314644","journal-title":"Biochemistry"},{"key":"184_CR143","doi-asserted-by":"publisher","first-page":"14637","DOI":"10.1021\/bi020574b","volume":"41","author":"WJ Wedemeyer","year":"2002","unstructured":"Wedemeyer WJ, Welker E, Scheraga HA (2002b) Proline cis\u2212trans isomerization and protein folding. Biochemistry 41:14637\u201314644","journal-title":"Biochemistry"},{"key":"184_CR144","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cell.2009.07.033","volume":"139","author":"RS Williams","year":"2009","unstructured":"Williams RS, Dodson GE, Limbo O, Yamada Y, Williams JS, Guenther G, Classen S, Glover JN, Iwasaki H, Russell P, Tainer JA (2009) Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 139:87\u201399","journal-title":"Cell"},{"key":"184_CR145","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1021\/jp5013297","volume":"118","author":"J Xia","year":"2014","unstructured":"Xia J, Levy RM (2014) Molecular dynamics of the proline switch and its role in Crk signaling. J Phys Chem B 118:4535\u20134545","journal-title":"J Phys Chem B"},{"key":"184_CR146","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00007890-198607000-00013","volume":"42","author":"K Yuzawa","year":"1986","unstructured":"Yuzawa K, Kondo I, Fukao KYI, Hamaguchi H (1986) Mutagenicity of cyclosporine. Induction of sister chromatid exchange in human cells. Transplantation 42:61\u201363","journal-title":"Transplantation"},{"key":"184_CR147","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.drudis.2022.05.026","volume":"27","author":"P Zhan","year":"2022","unstructured":"Zhan P, Yu B, Ouyang L (2022) Drug repurposing: An effective strategy to accelerate contemporary drug discovery. Drug Discov Today 27:1785\u20131788","journal-title":"Drug Discov Today"},{"key":"184_CR148","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.febslet.2013.01.028","volume":"587","author":"XC Zhang","year":"2013","unstructured":"Zhang XC, Wang WD, Wang JS, Pan JC (2013) PPIase independent chaperone-like function of recombinant human Cyclophilin A during arginine kinase refolding. FEBS Lett 587:666\u2013672","journal-title":"FEBS Lett"},{"key":"184_CR149","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1093\/nar\/gkf612","volume":"30","author":"S Zhao","year":"2002","unstructured":"Zhao S, Renthal W, Lee EY (2002) Functional analysis of FHA and BRCT domains of NBS1 in chromatin association and DNA damage responses. Nucleic Acids Res 30:4815\u20134822","journal-title":"Nucleic Acids Res"},{"key":"184_CR150","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1158\/0008-5472.CAN-08-0639","volume":"68","author":"J Zheng","year":"2008","unstructured":"Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV (2008) Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res 68:7769\u20137778","journal-title":"Cancer Res"},{"key":"184_CR151","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc.2016.49","volume":"16","author":"XZ Zhou","year":"2016","unstructured":"Zhou XZ, Lu KP (2016) The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. Nat Rev Cancer 16:463\u2013478","journal-title":"Nat Rev Cancer"},{"key":"184_CR152","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nm.3867","volume":"21","author":"D Zhu","year":"2015","unstructured":"Zhu D, Wang Z, Zhao J-J, Calimeri T, Meng J, Hideshima T, Fulciniti M, Kang Y, Ficarro SB, Tai Y-T et al (2015) The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med 21:572\u2013580","journal-title":"Nat Med"},{"key":"184_CR153","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/emmm.201201760","volume":"5","author":"J Zhu","year":"2013","unstructured":"Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E et al (2013) A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med 5:353\u2013365","journal-title":"EMBO Mol Med"},{"key":"184_CR154","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tcb.2013.09.003","volume":"24","author":"M Zimmermann","year":"2014","unstructured":"Zimmermann M, de Lange T (2014) 53BP1: pro choice in DNA repair. Trends Cell Biol 24:108\u2013117","journal-title":"Trends Cell Biol"},{"key":"184_CR155","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nsmb.3274","volume":"23","author":"D Zong","year":"2016","unstructured":"Zong D, Ray Chaudhuri A, Nussenzweig A (2016) More end resection is not merrier. Nat Struct Mol Biol 23:699\u2013701","journal-title":"Nat Struct Mol Biol"},{"key":"184_CR156","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/pro.5560010903","volume":"1","author":"LD Zydowsky","year":"1992","unstructured":"Zydowsky LD, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA, Ho SI, Walsh CT (1992) Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci 1:1092\u20131099","journal-title":"Protein Sci"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-024-00184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-024-00184-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-024-00184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:47:29Z","timestamp":1779122849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-024-00184-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":159,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,9]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1038\/s44319-024-00184-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.06.27.546694","asserted-by":"object"}]},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}